0001209191-22-041962.txt : 20220712 0001209191-22-041962.hdr.sgml : 20220712 20220712182407 ACCESSION NUMBER: 0001209191-22-041962 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220527 FILED AS OF DATE: 20220712 DATE AS OF CHANGE: 20220712 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Collins Kevin Walter CENTRAL INDEX KEY: 0001870312 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39976 FILM NUMBER: 221079868 MAIL ADDRESS: STREET 1: C/O LUCIRA HEALTH, INC. STREET 2: 1412 62ND STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lucira Health, Inc. CENTRAL INDEX KEY: 0001652724 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 272491037 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1412 62ND STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (814) 574-1546 MAIL ADDRESS: STREET 1: 1412 62ND STREET CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: DiAssess Inc. DATE OF NAME CHANGE: 20150908 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-27 0 0001652724 Lucira Health, Inc. LHDX 0001870312 Collins Kevin Walter C/O LUCIRA HEALTH, INC. 1412 62ND STREET EMERYVILLE CA 94608 0 1 0 0 Chief Revenue Officer Common Stock 2022-05-27 4 S 0 37109 2.00 D 364968 D These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 18, 2021 for 396,975 shares. Includes 5,102 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on February 20, 2022. /s/ Dan George, Attorney-in-Fact for Kevin W. Collins 2022-07-12